Pharmacists urge caution on weight loss drug
30 April 2009
Pharmacists have been urged to sell the weight loss drug alli only to patients who have undergone a consultation and have a BMI of 28 or higher.
The call from the Royal Pharmaceutical Society of Great Britain (RPSGB) comes after two Sunday newspapers reported cases of pharmacies not complying with regulations around the sale of the drug.
David Pruce, director of policy at the RPSGB, said: ‘Both the society and GSK, which manufactures orlistat, developed and disseminated guidance and training resources for pharmacists in anticipation of the medicine’s launch.
‘It is disappointing that some pharmacies have not followed the guidance. It is important to emphasise the need to closely follow the requirements for selling orlistat.’
sanjay.tanday@haymarket.com
Comment below and tell us what you think
Additional Information
Latest jobs Jobs web feed
- Salaried GP The Practice plc £75-85k FTE +NHS pension, Ely or Leicester
- Regional Clinical Leads The Practice plc Salary £95-105k FTE + NHS pension, Leicester or Sheffield
- Salaried/Lead GPs Malling Health Competitive, role dependant, NHS Pension and defence fees reimbursed, Nationwide
- Locums GP Wolverhampton Pegasus Medical £70 per hour, Wolverhampton and West Midlands long term
- Locum GP Leeds and Surrounding Area Pegasus Medical £70 - £75 per hour, Leeds and Yorkshire long term
- Locums GP Walsall Pegasus Medical £70 per hour, Walsall and West Midlands long term
Most read
Most commented
MIMS Drug Search
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.
